mProX™ Human PPARD Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Nuclear Receptor
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Jessica
Verified Customer
Michael
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 Induction of the expression of PPAR by doxycycline in established cell lines.
For five days, these cell lines were grown in the presence of Dox at concentrations of 0, 0.01, 0.1, or 1000 ng/ml, which promoted the expression of PPARs in a dose-dependent way.
Ref: Tachibana, Keisuke, et al. "Gene expression profiling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing different PPAR isoforms." Nuclear receptor 3 (2005): 1-17.
Pubmed: 16197558
DOI: 10.1186/1478-1336-3-3
Research Highlights
Although the expression of peroxisome proliferator-activated receptor-δ (PPARD) is elevated in several major human malignancies, its involvement in metastasis in cancer cells is still unclear.
Zuo, Xiangsheng, et al. "Metastasis regulation by PPARD expression in cancer cells." JCI insight 2.1 (2017).
Pubmed:
28097239
DOI:
10.1172/jci.insight.91419
APC mutations trigger abnormal β-catenin signaling, which initiates colorectal cancer; however, extra molecular processes are needed for colorectal cancer growth. A downstream target of β-catenin, PPAR-delta (PPARD), is increased in colorectal cancer.
Liu, Yi, et al. "Pleiotropic effects of PPARD accelerate colorectal tumorigenesis, progression, and invasion." Cancer research 79.5 (2019): 954-969.
Pubmed:
30679176
DOI:
10.1158/0008-5472.CAN-18-1790